The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Altered 5-Hydroxytryptamine Signaling in Patients With Constipation- and Diarrhea-Predominant Irritable Bowel Syndrome
Open accessAbstract
Background & aims Evidence suggests that postprandial platelet-depleted plasma 5-hydroxytryptamine (5-HT) concentrations may be abnormal in irritable bowel syndrome (IBS). However, interpretation of the data has been hampered by the variable methodology and rather small numbers used in previous studies. Therefore, the aim of this study was to measure concentrations of platelet-depleted plasma 5-HT and its metabolite 5-HIAA under fasting and fed conditions in a large group of patients with diarrhea-predominant (d-) and constipation-predominant (c-) IBS, compared with controls. The ratio of plasma 5-HIAA:5-HT and platelet stores was also assessed.Methods Twenty-nine c-IBS patients (aged, 19-53 years), 55 d-IBS patients (aged, 19-52 years), and 35 healthy volunteers (aged, 18-46 years) had platelet-depleted plasma 5-HT/5-HIAA concentrations measured using reverse-phase, high-performance liquid chromatography with fluorimetric detection before and after a standard meal.Results d-IBS patients had raised platelet-depleted plasma 5-HT concentrations under fasting and fed conditions (P < .05). However, the postprandial relative to fasting concentration was similar to controls. In contrast, c-IBS patients failed to show an increase in platelet-depleted plasma 5-HT concentration with meal ingestion compared with controls (P < .01). c-IBS was associated with decreased 5-HIAA (P < .01) but normal 5-HIAA:5-HT ratio and d-IBS with normal 5-HIAA concentrations but reduced 5-HIAA:5-HT ratio (P < .005). C-IBS but not d-IBS patients had increased platelet 5-HT.Conclusions These results support the concept that d-IBS is characterized by reduced 5-HT reuptake, whereas impaired release may be a feature of c-IBS. These results also provide a rational basis for current pharmacologic approaches involving modulation of different 5-HT receptors in c- and d-IBS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Changes in gastrointestinal motility may be influenced by alterations in serotonin (5-Hydroxytryptamine (5-HT)) metabolism, 49 with high levels reported in patients with IBS-D, and low levels in IBS-C.50”
From British Society of Gastroenterology guidelines on the management of irritable bowel syndrome (2021) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Coates, M. D., Mahoney, C. R., Linden, D. R., Sampson, J. E., Chen, J. C., Blaszyk, H., Crowell, M. D., Sharkey, K. A., Gershon, M. D., & Mawe, G. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.013 · Cited by 761
Serotonin: A Mediator of The Brain–Gut Connection
Kim, D.-Y., & Camilleri, M. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03177.x · Cited by 448
Little, K. Y., McLaughlin, D. P., Zhang, L., Livermore, C. S., Dalack, G. W., McFinton, P. R., DelProposto, Z., Hill, E. M., Cassin, B. J., Watson, S. J., et al. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.2.207 · Cited by 382
Cann, P. A., Read, N. W., Brown, C., Hobson, N., & Holdsworth, C. D. (1983) · Gut · doi:10.1136/gut.24.5.405 · Cited by 365
Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome
Dunlop, S. P., Coleman, N. S., Blackshaw, E., Perkins, A. C., Singh, G., Marsden, C. A., & Spiller, R. E. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00726-8 · Cited by 355
Chey, W. Y., Jin, H. O., Lee, M. H., Sun, S. W., & Lee, K. Y. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03804.x · Cited by 347
The motility of the pelvic colon
Connell, A. M. (1962) · Gut · doi:10.1136/gut.3.4.342 · Cited by 315
Bearcroft, C. P., Perrett, D. I., & Farthing, M. J. G. (1998) · Gut · doi:10.1136/gut.42.1.42 · Cited by 303
Research works printed but not linked: 1
- Whitaker, 1996, Measurement of platelet rich plasma 5-HT and platelet poor plasma 5-HIAA and 5-HT in normal adults, Ann Clin Biochem, 537, 341
Cited by
Sorted by citations
Items 301–355 of 355
A model for irritable bowel syndrome and anxiety comorbidities in relation to alcohol use disorders
Vashkevich, K., Janiuk, K., & Maleki, N. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1161130 · Cited by 1
“However, it is thought to be a multifactorial condition with multiple factors playing a central role in the pathophysiology of IBS (17), including a putative role for abnormalities involving serotonergic signaling mechanisms (14, 18, 19).”
BackgroundRouseti, G. M., Fischer, A., Rathfelder, N., Grimes, K., Waldt, A., Cuttat, R., Schuierer, S., Wild, S. A., Jivkov, M., Dubost, V., et al. (2024) · Toxicology · doi:10.1016/j.tox.2024.154028 · Cited by 1
Circadian rhythm homeostasis biomarkers: current landscape and emerging frontiers
Li, S., Zhang, C., Lin, Y., & Wang, S. (2025) · Oral Science and Homeostatic Medicine · doi:10.26599/oshm.2025.9610028 · Cited by 1
Hoedt, E. C., Burns, G. L., Hedley, K. E., Waller, S. E., Sánchez, T. C., Chisholm, O., MacCallum, H., Richardson, S., Suthers, B., Pepper, E., et al. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101218 · Cited by 1
“…alterations to serotonin levels are thought to contribute to many of the other non-motor symptoms, such as fatigue, sleep disturbances, anxiety and depression(Wilson et al., 2018), whereas in IBS-C they may perpetuate visceral hypersensitivity and impaired barrier function (Atkinson et al., 2006).”
Lobo, B. (2013) · TDX (Tesis Doctorals en Xarxa) · Cited by 1
Understanding the Pathophysiology of IBS
Barbara, G., Dolci, M., Cremon, C., Barbaro, M., Bellacosa, L., Fucili, A., & Stanghellini, V. (2013) · EMJ Gastroenterology · doi:10.33590/emjgastroenterol/10314657 · Cited by 1
Padelli, M., Bruno, C., Lemarchand, J., Vourc’h, P., Andres, C. R., Blasco, H., & Bretagne, I. B. (2019) · Annales de biologie clinique · doi:10.1684/abc.2019.1432 · Cited by 1
INTER-RELATIONSHIP BETWEEN THE BRAIN-INTESTINE AXIS AND THE SEROTONERGIC MECHANISM IN OBESITY
Tolloto, G. H. V., & Saragiotto, L. (2022) · Health and Society · doi:10.51249/hs.v2i01.674 · Cited by 1
Evaluating Small Intestinal Motility in a Rat Model of Adolescent Irritable Bowel Syndrome
Sato, M., Kudo, T., Arai, N., Kyodo, R., HOSOI, K., Sakaguchi, K., Ikuse, T., Jimbo, K., Ohtsuka, Y., & Shimizu, T. (2022) · Juntendō Igaku/Juntendo igaku · doi:10.14789/jmj.jmj21-0050-oa · Cited by 1
“5-HT released by enterochromaffin cells ( EC cells ) within the mucosa via intraluminal distension or irritation stimulates 5-HT3 receptors located on the primary afferent neurons of both splanchnic and vagal fibers, thereby modulating a sensory response 10 ) .”
BackgroundPathogenese funktioneller gastrointestinaler Störungen
Légeret, C., & Bolten, M. I. (2022) · Springer eBooks · doi:10.1007/978-3-662-64253-5_5 · Cited by 1
Alimentation, Bacterial Metabolites, and Host Intestinal Epithelium
Blachier, F. (2023) · Springer eBooks · doi:10.1007/978-3-031-26322-4_4 · Cited by 1
Mukai, H., Takanashi, M., Ogawara, K., Maruyama, M., & Higaki, K. (2023) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2023.11.010 · Cited by 1
Pain in irritable bowel syndrome
Zielińska, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821324-7.00010-1 · Cited by 1
Irritable bowel syndrome in a patient with obesity: accident or regularity?
Simanenkov, V. I., Викторович, Т. С., & Dekkanova, V. D. (2019) · Medical alphabet · doi:10.33667/2078-5631-2019-2-13(388)-14-19 · Cited by 1
Malik, A., Saha, S., Morya, R. K., Bhadada, S. K., & Rana, S. V. (2021) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm20211 · Cited by 2
Diarrhea syndrome: new accents of patient curation during COVID-19 pandemic
Gaus, O. V., & Livzan, M. A. (2021) · Russian Medical Inquiry · doi:10.32364/2587-6821-2021-5-6-446-452 · Cited by 1
Peripheral and central factors in the pathophysiology of irritable bowel syndrome
Posserud, I. (2007) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Halliez, M. C. M. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/27133 · Cited by 1
Alarcón–Fernández, O., Álvarez-Fernández, J.-A., Baudet, J., Pérez-Quintero, R., Río, A. S.-D., Borja-Gutiérrez, E., & Borque‐Barrera, P. (2008) · Medicina Clínica · doi:10.1157/13121101 · Cited by 1
Ford, A., Moayyedi, P., & Talley, N. (2010) · Wiley eBooks · doi:10.1002/9781444314403.ch21
Hayot, G., Massonot, M., Keime, C., Faure, E., & Golzio, C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.06.463249 · Cited by 1
Актуальные вопросы диагностики и лечения синдрома раздраженной кишки
Пойгнер, И. Ю., & Чичерина, Е. Н. (2012) · Вятский медицинский вестник
Gut Inflammation in Irritable Bowel Syndrome
Gwee, K. (2013) · Wiley eBooks · doi:10.1002/9781118444689.ch9
Arnol, V. (2012) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/2765
Plasma serotonin level in left-sided colonic diverticulosis: A pilot study
Neubauer, K., Krzystek‐Korpacka, M., & Paradowski, L. (2012) · Open Medicine · doi:10.2478/s11536-012-0041-9
Tegaserod in the treatment of constipation-predominant functional gastrointestinal disorders
Agrawal, A., & Whorwell, P. J. (2006) · Therapy · doi:10.1586/14750708.3.4.475
Self-citationvan Kerkhoven, L. A. S. (2009) · Radboud Repository (Radboud University)
Clinical and economic profile of prucalopride in the treatment of chronic constipation in women
Stanghellini, V., & Eandi, M. (2012) · Farmeconomia Health economics and therapeutic pathways · doi:10.7175/fe.v13i3.271
Niesler, B., Kapeller, J., Fell, C., Atkinson, W., Möller, D., Cox, V. A., Fischer, C., Whorwell, P. J., Pfister, P. J., Rappold, G., et al. (2009) · Research Explorer (The University of Manchester)
Self-citationGuilarte, M. (2014) · TDX (Tesis Doctorals en Xarxa)
Thijssen, A. Y. (2015) · Research Publications (Maastricht University) · doi:10.26481/dis.20151119at
Targeting cyclic GMP signaling for the treatment of gastrointestinal diseases
Sharman, S. K. (2017)
Wiklund, I., Foster, T., Travers, K., Fortea, J., & Prior, M. (2011) · Value in Health · doi:10.1016/j.jval.2011.08.876
Is Irritable Bowel Syndrome over Diagnosed in Duhok City Community-Iraq?
Sefar, Mohamad, Haj, Waleed, Jameel, Omar, & Barwari (2012) · Journal of US-China Medical Science · doi:10.17265/1548-6648/2012.04.007
Black, C. J. (2021) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Noh, H. D., Kim, M. J., Cho, I.-H., & Kim, S. Y. (2021) · 동의생리병리학회지 · doi:10.15188/kjopp.2021.10.35.5.199
Salmoirago‐Blotcher, E., Crawford, S. L., & Ockene, I. S. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.10.006
Mechanism, Pathophysiology and Herbal Management-A Review on Irritable Bowel Syndrome
Wal, A., Wal, P., Verma, N., Rai, A. K., & Vatsha, P. (2022) · The Natural Products Journal · doi:10.2174/2210315512666220624163105
Constipation and Fecal Incontinence in the Elderly
Richter, B. I., Skryd, A. F., & Smukalla, S. M. (2022) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-022-00401-1
COVID in children and the digestive system: clinical and pathogenetic correlation
Печкуров, Д. В., Romanova, A. A., Александровна, Т. А., & Poretskova, G. Y. (2022) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-202-6-41-49
Paley, E. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19122-0.00002-9
Mironov, D. S., Александрович, С. И., Trubetskaya, T. N., Шитова, Н. С., & Александрович, П. В. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-217-9-168-176
Gaus, O. V., Fedorenko, A. S., & Судакова, А. Н. (2025) · Medical alphabet · doi:10.33667/2078-5631-2024-34-36-41
Gregersen, K. (2013) · NORA - Norwegian Open Research Archives
Wu, J., Du, S., Sun, Y., Ye, J., & Xu, Y. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1771521
Zhang, C., Mei, Y., Wu, H., Wang, T., & Han, Z. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1784483
“Atkinson et al. (63) demonstrated that 5-HT 3 antagonists delayed defecation and improved stool consistency and urgency.”
Saudi consensus statements on the management of irritable bowel syndrome
Alzahrani, M. A., Alzubide, S. R., Abufarhaneh, E. H., Alqaraawi, A., Al-Amro, R., Alhalafi, M., Alamr, A., Alsulaimi, M. S., Alshumrani, W., Alotaibi, S., et al. (2026) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_472_25
Irritable bowel syndrome like symptoms in inflammatory bowel disease: Research progress
Zhou, S., Dong, H., Zhang, K., & Jiang, B. (2026) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v34.i4.325
Intestino irritable: una enfermedad orgánica en 2026
Díaz, J. A. U., Fernández, H. M., Ordoñez, J. S. F., Cheng, H. G. C., Espinoza‐Ríos, J., Parra, L. O., & Regino, W. O. (2026) · Revista de Gastroenterología del Perú · doi:10.47892/rgp.2026.462.2262
Kim, J., Park, S. J., Huh, C., & Shin, C. H. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11238-w
Han, J., Lang, Y., Yao, K., & Mi, J. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1992567
“CCK, cholecystokinin; EC, enterochromaffin cell; EEC, enteroendocrine cell; FFAR1/2, free fatty acid receptors 1 and 2; fMRI, functional magnetic resonance imaging; GLP-1, glucagon-like peptide-1; GPBAR1/TGR5, G protein-coupled bile acid receptor 1/Takeda G protein-coupled receptor 5; IBS, irritable bowel syndrome; PY…”
InfluentialSerotonin and Its Role in Colonic Function and in Gastrointestinal Disorders
Costedio, M. M., Hyman, N., & Mawe, G. M. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0763-3 · Cited by 170
Metadata
- Authors
- Atkinson, W., Lockhart, S., Whorwell, P. J., Keevil, B., & Houghton, L. A.
- Corresponding author
- Houghton, Lesley A.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 130
- Issue
- 1
- Pages
- 34-43
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2128077096
- Cited by
- 355
- References
- 41
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 15 · 2023: 21 · 2022: 20 · 2021: 30 · 2020: 18 · 2019: 12 · 2018: 11 · 2017: 15 · 2016: 15 · 2015: 12 · 2014: 30 · 2013: 16 · 2012: 20
- FWCI
- 18.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- irritable bowel syndrome, irritable bowel syndrome with constipation, diarrhea-predominant irritable bowel syndrome, serotonin, 5-hydroxyindoleacetic acid, serotonin uptake, serotonin release, serotonin receptors
- MeSH terms
- Adult, Chromatography, High Pressure Liquid, Constipation, Diarrhea, Fasting, Female, Humans, Hydroxyindoleacetic Acid, Male, Middle Aged, Serotonin, Signal Transduction, Case-Control Studies, Postprandial Period, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
